Keywords: روزیگلیتازون; PPAR peroxisome proliferator-activated receptor; BSA bovine serum albumin; Rosiglitazone; Valsartan; Diabetes mellitus; Fluorescence spectroscopy, oligomerisation;
مقالات ISI روزیگلیتازون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: روزیگلیتازون; adipose tissue; glucose regulation; inflammation; Korean Red Ginseng; rosiglitazone;
Keywords: روزیگلیتازون; Diabetes; Glucagon-like peptide-1 (GLP-1); mimetics; Dipeptidil peptidase-4 (DPP-4); antagonists; Sodium glucose co-transporter-2 (SGLT-2); antagonists; Pioglitazone; Rosiglitazone;
Keywords: روزیگلیتازون; AgRP; agouti-related peptide; ARC; arcuate; CRF; corticotropin releasing factor; DDC; dopa decarboxylase; GLUT1, 2, 3, and 8, respectively; glucose transporter 1, 2, 3, and 8; IR; insulin receptor; ICV; intracerebroventricular; NPY; neuropeptide Y; NPYr1,
Keywords: روزیگلیتازون; Rosiglitazone; Peroxisome proliferator-activated receptor-γ; Lipopolysaccharide; Inflammation; Fetal death
Keywords: روزیگلیتازون; 3β-HSD I; 3β-hydroxysteroid dehydrogenase type I; CL; corpus luteum; DBT; dibutyltin; DMSO; dimethyl sulfoxide; FCS; fetal calf serum; hCG; human chorionic gonadotropin; GR; glucocorticoid receptor; LG; LG100268; LUC; luciferase; MEM; minimal essential
Keywords: روزیگلیتازون; Acute liver injury; Dimethylarginine dimethylaminohydrolase; Asymmetric dimethylarginine; PPAR-γ agonists; Rosiglitazone
Keywords: روزیگلیتازون; Cationic emulsion; Gene delivery; Type 2 diabetes; Adiponectin; Rosiglitazone
Keywords: روزیگلیتازون; Diabetes; Rosiglitazone; Discontinuation;
Keywords: روزیگلیتازون; AUC; Area under the curve; i.p.; Intraperitoneal; LSD; Least significant difference; NIH; National Institutes of Health; PO; Per os; PPAR; Peroxisome proliferator-activated receptor; RPM; Revolutions per minute; t; Time; UBC; University of British Columbi
Keywords: روزیگلیتازون; Pioglitazone; Rosiglitazone; Thiazolidinediones; Fractures; Meta-analysis
Keywords: روزیگلیتازون; ANOVA; one-way analysis of variance; Cf-CHS; fucosylated chondroitin sulphate from Cucumaria frondosa; ECL; super-enhanced chemiluminescence; HE; hematoxylin and eosin; HFSD; high-fat high-sucrose diet; HOMA-IR; homeostasis model assessment of insulin res
Keywords: روزیگلیتازون; Î2-TGZ; Î2-Troglitazone; TGZ; Troglitazone; TZD; Thiazolidinediones; RGZ; Rosiglitazone; 2-DG; 2-deoxyglucose; ER; endoplasmic reticulum; CGZ; Ciglitazone; UPR; unfolded protein response; Cancer; Glucose metabolism; 2-deoxyglucose, Thiazolidinediones; W
Keywords: روزیگلیتازون; PR; progesterone receptor; PIC; pro-inflammatory cytokines; P4; progesterone; Erk; extracellular-signal-regulated kinase 1/2; p53; protein 53; AKT; protein kinase B; TRAF2; tumor necrosis factor receptor-associated factor 2; PR-KO; PR knockout; Mif; mifep
Keywords: روزیگلیتازون; 5-HT; 5-hydroxy tryptamine; NMDA; N-methyl-d-aspartate; STL; step through latency; UD; Urtica dioica; Diabetic neuropathy; Hypoalgesia; Memory; Rosiglitazone; Morris water maze; Cognitive impairment;
The antidepressant effects of rosiglitazone on rats with depression induced by neuropathic pain
Keywords: روزیگلیتازون; Rosiglitazone; Depression; Neuropathic pain;
Identification and expression patterns of adipokine genes during adipocyte differentiation in the Tibetan goat (Capra hircus)
Keywords: روزیگلیتازون; FGF21; fibroblast growth factor 21; APLN; apelin; RETN; resistin; NAMPT; visfatin; RELM; resistin-like molecule; NAD; nicotinamide adenine dinucleotide; ORO; Oil red O; TG; triglyceride; PPARγ; peroxisome proliferator-activated receptor γ; Goat; Adipoki
The Involvement of PPARs in the Selective Regulation of Brain CYP2D by Growth Hormone
Keywords: روزیگلیتازون; CYP2D; cytochrome P450 2D; DCN; deep cerebellar nuclei; GH; growth hormone; GHR; growth hormone receptor; PPARα; peroxisome proliferator activated receptors alpha; PPARβ; peroxisome proliferator activated receptors beta; PPARγ; peroxisome proliferator
PPARγ agonist rosiglitazone switches fuel preference to lipids in promoting thermogenesis under cold exposure in C57BL/6 mice
Keywords: روزیگلیتازون; Peroxisome proliferator-activated receptor γ (PPARγ); Rosiglitazone; Brown adipose tissue; Thermogenesis; Metabolomics;
Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren's syndrome patients imposed by intrinsic NF-κB activation
Keywords: روزیگلیتازون; Epithelial cells; PPARγ; NF-κB; IL-1β; Rosiglitazone; Microarray analysis; SS; Sjögren's syndrome; SG; salivary glands; SGEC; ductal salivary gland epithelial cell lines; PPARγ; peroxisome-proliferator-activated receptor-γ; Rosi; Rosiglitazone; Cig;
Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors
Keywords: روزیگلیتازون; PDE9 inhibitors; Alzheimer's disease; Type 2 diabetes mellitus; Rosiglitazone; Molecular docking; Dynamics simulation;
Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH
Keywords: روزیگلیتازون; Pulmonary arterial hypertension; PPAR-γ; Rosiglitazone; PLGA particles; Inhalational delivery;
Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes
Keywords: روزیگلیتازون; Type 2 diabetes; Bone turnover markers; Insulin; Metformin; Rosiglitazone;
Co-Activation of Glucocorticoid Receptor and Peroxisome Proliferator-Activated Receptor-γ in Murine Skin Prevents Worsening of Atopic March
Keywords: روزیگلیتازون; AD; atopic dermatitis; BMDC; bone marrowâderived dendritic cell; DEX; dexamethasone; e.c; epicutaneous; GC; glucocorticoid; GR; glucocorticoid receptor; HDM; house dust mite; MC; monocyte-derived cell; PBS; phosphate buffered saline; PPAR; peroxisome pr
The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity
Keywords: روزیگلیتازون; Cancer cells; PPARγ agonist; PPARγ antagonist; Therapeutic agents; Tumorigenicity; ACC; Acetyl-CoA carboxylase; AKR1B10; Alde-keto reductase 1B10; Alpha-ESA; Alpha-eleostreac acid; ACLY; ATP citrate lyase; BADGE; Bisphenol-A-diglycidyl-etter; CSCs; Canc
Improvement of glucocorticoid-impaired thymus function by dihydromyricetin via up-regulation of PPARγ-associated fatty acid metabolism
Keywords: روزیگلیتازون; GCs; glucocorticoids; DMY; dihydromyricetin; DEX; dexamethasone; Ros; rosiglitazone; PPARγ; peroxisome proliferator-activated receptor γ; DNFB; 2, 4-dinitro fluoro benzene; DMSO; dimethyl sulfoxide; BADGE; bisphenol A diglycidyl ether; RTEs; recent thym
Effects of bisphenol A on metabolism and evidences of a mode of action mediated through endocrine disruption
Keywords: روزیگلیتازون; Bisphenol A; BPA; Endocrine disruption; Obesity; Type 2 diabetes; Insulin; BAT; brown adipose tissue; BMI; body mass index; bw; body weight; DES; diethylstilbestrol; DM; Diabete mellitus; ED; endocrine disruptor; eGFR; estimated glomerular filtration; ERR
Raffinose from Costus speciosus attenuates lipid synthesis through modulation of PPARs/SREBP1c and improves insulin sensitivity through PI3K/AKT
Keywords: روزیگلیتازون; Anti-diabetes; Anti-adipogenesis; Lipid metabolism; Insulin signaling; ACC; acetyl-CoA carboxylase; ACO; Acyl CoA Oxidase; Comp C; Compound C; CSEW; Costus speciosus ethanolic water extract; DMEM; Dulbecco's Modified Eagle Medium; FAS; fatty acid synthase
Oroxin A from Oroxylum indicum prevents the progression from prediabetes to diabetes in streptozotocin and high-fat diet induced mice
Keywords: روزیگلیتازون; Oroxin A; Prediabetes; Type 2 diabetes; PPARγ; Mechanism; 2h-PG; 2-h postprandial glucose; ALT; alanine transaminase; AST; aspartate transaminase; AUC; area under the curve; CMC-Na; Sodium carboxymethylcellulose; CαRMSD; Cα root mean square deviation;
New insights into molecular mechanisms of rosiglitazone in monotherapy or combination therapy against cancers
Keywords: روزیگلیتازون; Rosiglitazone; Anticancer effects; Molecular mechanisms; Combination therapy; Clinical trials; Radiosensitivity;
High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification
Keywords: روزیگلیتازون; CKD; chronic kidney disease; PPARγ; peroxisome proliferator-activated receptor-gamma; VMSCs; mouse vascular smooth muscle cells; Mecp2; methyl-CpG binding protein 2; Runx2; runt-related transcription factor 2; BMP-2; bone morphogenic proteins-2; BUN; blo
Rosiglitazone rescues human neural stem cells from amyloid-beta induced ER stress via PPARγ dependent signaling
Keywords: روزیگلیتازون; PPARγ; Rosiglitazone; Aβ; hNSCs; ER stress;
Using bisphenol A and its analogs to address the feasibility and usefulness of the CALUX-PPARγ assay to identify chemicals with obesogenic potential
Keywords: روزیگلیتازون; Peroxisome proliferator-activated nuclear hormone receptor γ (PPARγ); CALUX; Obesogens; In vitro screening; Metabolism; Bisphenols; 15dPGJ2; 15-deoxy-Î12,14-prostaglandin J2; 3OH BDE-47; 3-hydroxy BDE-47; 5OH BDE-47; 5-hydroxy BDE-47; BADGE; Bisphenol
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Keywords: روزیگلیتازون; 15d-PGJ2; 15-deoxy-D12, 14prostaglandin J2; 15(S)-HETE; 15(S)-hydroxyeicosatetraenoic acid; ADP; adenosine diphosphate; AGE; advanced glycan end product; AMPA; α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid; ARE; antioxidant response element; AS; a
Structure-activity relationships of rosiglitazone for peroxisome proliferator-activated receptor gamma transrepression
Keywords: روزیگلیتازون; PPAR; Transrepression; Rosiglitazone;
Research articleRosiglitazone pretreatment influences thrombin-induced phagocytosis by rat microglia via activating PPARγ and CD36
Keywords: روزیگلیتازون; Cerebral hemorrhage; Microglial cells; Rosiglitazone; Phagocytosis; PPARγ; CD36;
Time- and cell-resolved dynamics of redox-sensitive Nrf2, HIF and NF-κB activities in 3D spheroids enriched for cancer stem cells
Keywords: روزیگلیتازون; AUR; auranofin; CA9; carbonic anhydrase IX; CDKN1B; cyclin-dependent kinase inhibitor 1B (p27); CSC; cancer stem cell; DMOG; dimethyloxalylglycine; GSH; glutathione; HIF; hypoxia inducible factor; MUC2; mucin2; NCL; nucleolin; NFE2L2 or Nrf2; nuclear fact
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model
Keywords: روزیگلیتازون; Rosiglitazone; PPAR gamma agonists; Radiation-induced toxicity; Oral mucositis; Radioprotection;
PPAR-γ agonist rosiglitazone reduces autophagy and promotes functional recovery in experimental traumaticspinal cord injury
Keywords: روزیگلیتازون; Spinal cord injury; Rosiglitazone; Autophagy;
Effects of Rosiglitazone on the Outcome of Experimental Periapical Lesions in Mice
Keywords: روزیگلیتازون; Apoptosis; gene expression; mice; microscopic analysis; osteocytes; periapical lesion; rosiglitazone;
Research paperThe neuroprotective role of rosiglitazone in advanced glycation end product treated human neural stem cells is PPARgamma-dependent
Keywords: روزیگلیتازون; rosiglitazone; PPARγ; hNSCs; AGEs; Neuroprotection;
Characterization of stem cell-derived liver and intestinal organoids as a model system to study nuclear receptor biology
Keywords: روزیگلیتازون; ChIP; chromatin immunoprecipitation; DIC; differential interference contrast; DM; differentiation medium; DSG; Di(N-succinimidyl) glutarate; EM; expansion medium; Fxr; farnesoid x receptor; IPA; Ingenuity Pathway Analysis; Lxr; Liver x receptor; NR; nucle
Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins
Keywords: روزیگلیتازون; Pioglitazone (PubChem CID: 4829); Rosiglitazone (PubChem CID: 77999); Troglitazone (PubChem CID: 29010888); 2,4-Thiazolidinedione (PubChem CID: 5437); 15d-PGJ2 (PubChem CID: 5311211); Docking; Molecular dynamics; Pioglitazone; Rosiglitazone; Troglitazone;
Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders
Keywords: روزیگلیتازون; Mitochondrial dysfunction; Neurodegenerative disorder; Mitochondrial dynamics; PGC-1 alpha; Mitochondrial biogenesis; Pioglitazone; Rosiglitazone;
A highly sensitive LC-MS/MS method for concurrent determination of sildenafil and rosiglitazone in rat plasma
Keywords: روزیگلیتازون; Sildenafil; Rosiglitazone; LC-MS/MS; Pharmacokinetics; Pulmonary arterial hypertension; Inhalational therapy;
Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells
Keywords: روزیگلیتازون; hepatocellular carcinoma; honokiol; PPARγ agonist; rosiglitazone
Rosiglitazone attenuates angiotensin II-induced C-reactive protein expression in hepatocytes via inhibiting AT1/ROS/MAPK signal pathway
Keywords: روزیگلیتازون; C-reactive protein; Rosiglitazone; Inflammation; Hepatocytes; Angiotensin II;
Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats
Keywords: روزیگلیتازون; Traumatic brain injury; PPARγ; Inflammation; Rosiglitazone; Behavioral; Cell survival;
Upregulation of MKP-7 in response to rosiglitazone treatment ameliorates lipopolysaccharide-induced destabilization of SIRT1 by inactivating JNK
Keywords: روزیگلیتازون; SIRT1; silent mating type information regulation 2 homolog 1; PPARγ; peroxisome proliferator-activated receptor γ; LPS; lipopolysaccharide; MKP-7; mitogen-activated protein kinase phosphatase-7; PGC-1α; peroxisome proliferator-activated receptor gamma
PPARγ signaling and emerging opportunities for improved therapeutics
Keywords: روزیگلیتازون; PPARγ; peroxisome proliferator-activated receptor gamma; TZD; thiazolidinedione; T2DM; type 2 diabetes mellitus; RGZ; rosiglitazone; 15d-PGJ2; 15-deoxy-D12,14-prostanglandin J2; PGC-1α; PPARγ co-activator-1α; RXR; retinoid X receptor; PPRE; peroxisome